[
1. Markovic BS, Kanjevac T, Harrell CR, Gazdic M, Fellabaum C, Arsenijevic N, Volarevic V. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases. Stem Cell Rev Rep. 2018;14:153-165.10.1007/s12015-017-9789-229177796
]Search in Google Scholar
[
2. Acovic A, Simovic Markovic B, Gazdic M, Arsenijevic A, Jovicic N, Gajovic N, Jovanovic M, Zdravkovic N, Kanjevac T, Harrell CR, Fellabaum C, Dolicanin Z, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis. Therap Adv Gastroenterol. 2018;11:1756284818793558.10.1177/1756284818793558610984130159037
]Search in Google Scholar
[
3. Acovic A, Gazdic M, Jovicic N, Harrell CR, Fellabaum C, Arsenijevic N, Volarevic V. Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract. Therap Adv Gastroenterol. 2018 Dec 6;11:1756284818815334.10.1177/1756284818815334629570030574192
]Search in Google Scholar
[
4. Vasovic M, Gajovic N, Brajkovic D, Jovanovic M, Zdravkovaic N, Kanjevac T. The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review. Cent Eur J Immunol. 2016;41:302-310.10.5114/ceji.2016.63131509938827833449
]Search in Google Scholar
[
5. Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases, and their oro-dental manifestations: Part 2: Ulcerative colitis. Br Dent J. 2017;222:53-57.10.1038/sj.bdj.2017.3728084352
]Search in Google Scholar
[
6. Elahi M, Telkabadi M, Samadi V, Vakili H. Association of oral manifestations with ulcerative colitis. :6.
]Search in Google Scholar
[
7. Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9:34-40.10.1034/j.1601-0825.2003.00879.x12617256
]Search in Google Scholar
[
8. Field EA, Allan RB. Oral ulceration - aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment Pharmacol Ther. 2003;18:949-962.10.1046/j.1365-2036.2003.01782.x14616160
]Search in Google Scholar
[
9. Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn’s disease. Br Dent J. 2016;221:794-799.10.1038/sj.bdj.2016.95427982000
]Search in Google Scholar
[
10. Patil DT, Moss AC, Odze RD. Role of Histologic Inflammation in the Natural History of Ulcerative Colitis. Gastrointest Endosc Clin N Am. 2016;26:629-640.10.1016/j.giec.2016.06.00927633592
]Search in Google Scholar
[
11. Lankarani KB. Oral manifestation in inflammatory bowel disease: A review. World J Gastroenterol. 2013;19:8571.10.3748/wjg.v19.i46.8571387050224379574
]Search in Google Scholar
[
12. Ruiz-Roca JA, Berini-Aytés L, Gay-Escoda C. Pyostomatitis vegetans. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 2005;99:447-454.10.1016/j.tripleo.2003.08.022
]Search in Google Scholar
[
13. Siegel MA, Jacobson JJ. Inflammatory bowel diseases and the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 1999;87:12-14.10.1016/S1079-2104(99)70287-8
]Search in Google Scholar
[
14. Jurge S, Hegarty AM, Hodgson T. Orofacial manifestations of gastrointestinal disorders. Br J Hosp Med. 2014;75:497-501.10.12968/hmed.2014.75.9.497
]Search in Google Scholar
[
15. Brito F, Barros FC de, Zaltman C, Pugas Carvalho AT, de Vasconcellos Carneiro AJ, Fischer RG, et al. Prevalence of periodontitis and DMFT index in patients with Crohn’s disease and ulcerative colitis. J Clin Periodontol. 2008;35:555-560.10.1111/j.1600-051X.2008.01231.x
]Search in Google Scholar
[
16. Habashneh RA, Khader YS, Alhumouz MK, Jadallah K, Ajlouni Y. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study: Inflammatory bowel disease and periodontitis. J Periodontal Res. 2012;47:293–8.10.1111/j.1600-0765.2011.01431.x
]Search in Google Scholar
[
17. Grossner-Schreiber B, Fetter T, Hedderich J, Kocher T, Schreiber S, Jepsen S. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33:478–84.10.1111/j.1600-051X.2006.00942.x
]Search in Google Scholar
[
18. Yarom N, Cantony U, Gorsky M. Prevalence of fissured tongue, geographic tongue and median rhomboid glossitis among Israeli adults of different ethnic origins. Dermatology. 2004; 209:88-94.10.1159/000079590
]Search in Google Scholar
[
19. Redman RS. Prevalence of geographic tongue, fissured tongue, median rhomboid glossitis, and hairy tongue among 3,611 Minnesota schoolchildren. Oral surgery, oral medicine, and oral pathology. 1970; 30:390-395.10.1016/0030-4220(70)90320-8
]Search in Google Scholar
[
20. Greene RM, Rogers RS, 3rd. Melkersson-Rosenthal syndrome: a review of 36 patients. Journal of the American Academy of Dermatology. 1989; 21:1263-1270.10.1016/S0190-9622(89)70341-8
]Search in Google Scholar
[
21. Daneshpazhooh M, Nazemi TM, Bigdeloo L, et al. Mucocutaneous findings in 100 children with Down syndrome. Pediatric dermatology. 2007; 24:317-320.10.1111/j.1525-1470.2007.00412.x17542890
]Search in Google Scholar
[
22. Mukamal LV, Ferreira AF, Jacques Cde M, et al. Cowden syndrome: review and report of a case of late diagnosis. International journal of dermatology. 2012; 51:1494-1499.10.1111/j.1365-4632.2011.05140.x23171017
]Search in Google Scholar
[
23. Du ZF, Xu CM, Zhao Y, et al. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma. European journal of dermatology: EJD. 2012; 22:476-480.10.1684/ejd.2012.177322668561
]Search in Google Scholar
[
24. Rivera-Serrano CM, Man LX, Klein S, Schaitkin BM. Melkersson-Rosenthal syndrome: a facial nerve center perspective. J Plast Reconstr Aesthet Surg. 2014;67:1050-4.10.1016/j.bjps.2014.04.01424874612
]Search in Google Scholar
[
25. Nisa L, Giger R. Lingua plicata. CMAJ. 2012;184(4):E241. doi:10.1503/cmaj.111255329169822291178
]Open DOISearch in Google Scholar
[
26. Reamy BV, Derby R, Blunt CW. Common tongue conditions in primary care. Am Fam Physician 2010;81:627-34.
]Search in Google Scholar
[
27. Picciani BL, Domingos TA, Teixeira-Souza T, Santos Vde C, Gonzaga HF, Cardoso-Oliveira J, Gripp AC, Dias EP, Carneiro S. Geographic tongue and psoriasis: clinical, histopathological, immunohistochemical and genetic correlation - a literature review. An Bras Dermatol. 2016;91:410-421.10.1590/abd1806-4841.20164288499909727579734
]Search in Google Scholar
[
28. Rakic M, Lekovic V, Nikolic-Jakoba N, Vojvodic D, Petkovic-Curcin A, Sanz M. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. Clin Oral Implants Res. 2013 Oct;24(10):1110–6.10.1111/j.1600-0501.2012.02518.x22708989
]Search in Google Scholar
[
29. Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, et al. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World J Gastroenterol. 2017 Nov 7;23(41):7387–96.10.3748/wjg.v23.i41.7387568584429151692
]Search in Google Scholar
[
30. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1756-1767.10.1053/j.gastro.2011.02.016377350721530742
]Search in Google Scholar
[
31. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29:42-45.10.1016/j.cdp.2004.10.00315734216
]Search in Google Scholar
[
32. Langer V, Vivi E, Regensburger D, Winkler TH, Waldner MJ, Rath T, Schmid B, Skottke L, Lee S, Jeon NL, Wohlfahrt T, Kramer V, Tripal P, Schumann M, Kersting S, Handtrack C, Geppert CI, Suchowski K, Adams RH, Becker C, Ramming A, Naschberger E, Britzen-Laurent N, Stürzl M. IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. J Clin Invest. 2019;129:4691-4707.10.1172/JCI124884681911931566580
]Search in Google Scholar
[
33. Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol. 2003;38:180-185.10.1080/0036552031000067212678335
]Search in Google Scholar
